Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized brand on Jan. 16.

The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an extensive scientific review of them.

The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be sold.

Zeller credited Gottlieb for advocating for the nicotine regulation within the Trump White House, after the Obama administration had fallen short. Obama officials had promised Zeller they would back rules to curb nicotine and menthol.

The U.S. Food and Drug Administration issued a rule to drastically reduce the amount of nicotine in cigarettes and other combusted tobacco products.

Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.

Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it will take a significant lobbying effort for it to go into effect.

The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the effort — or scrap it.

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products. It is the first time the agency has authorized the sale of nicotine pouches,

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, the first such authorization for nicotine pouches in the country. The authorized products pose lower risk of cancer and other serious health conditions than cigarettes and most smokeless tobacco products,